Express Pharma

Home
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads

Likes
Followers
Subscribers
Followers

Likes
Followers
Subscribers
Followers

Sign in

Welcome, Login to your account.

Forget password? Remember me

Sign in

Recover your password.

A password will be e-mailed to you.

Tuesday, November 19, 2024
Home
Digital Issue
Advertise With Us
About Us
- Subscriptions
- Contact Us
Submit Press Release
- Submit Guest Blogs
- Contributors Checklist
Network
Privacy Policy

Express Pharma - Express Pharma

Home
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads

Home
biologic license application

Browsing Tag

biologic license application

FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market: GlobalData

EP News Bureau Oct 31, 2023

GlobalData currently expects Lilly to resubmit lebrikizumab’s BLA in Q4 2023

SIGNUP FREE NEWSLETTER

First name

Last name

Your email

Stay With Us

Facebook Likes
Twitter Followers
Youtube Subscribers
Linkedin Follow us

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

SIGNUP FREE NEWSLETTER

First name

Last name

Your email

Sign in

Home
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads